ArticleNeuro-oncology advances
Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143.
Antonio Omuro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
pooled ittrialcites it